Deutsche Bank’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,085
Closed -$136K 4947
2021
Q1
$136K Buy
2,085
+699
+50% +$48.8K ﹤0.01% 3821
2020
Q4
$91K Buy
1,386
+423
+44% +$27.6K ﹤0.01% 3892
2020
Q3
$52K Buy
963
+92
+11% +$7.04K ﹤0.01% 3881
2020
Q2
$83K Buy
871
+252
+41% +$18.8K ﹤0.01% 3549
2020
Q1
$31K Sell
619
-38
-6% -$3.97K ﹤0.01% 3763
2019
Q4
$53K Buy
657
+87
+15% +$6.1K ﹤0.01% 3947
2019
Q3
$46K Sell
570
-5,028
-90% -$537K ﹤0.01% 3985
2019
Q2
$711K Buy
5,598
+780
+16% +$112K ﹤0.01% 3062
2019
Q1
$867K Buy
4,818
+2,020
+72% +$292K ﹤0.01% 3081
2018
Q4
$309K Sell
2,798
-7,155
-72% -$932K ﹤0.01% 3622
2018
Q3
$1.34M Buy
9,953
+305
+3% +$42K ﹤0.01% 3105
2018
Q2
$1.33M Buy
9,648
+2,077
+27% +$286K ﹤0.01% 3228
2018
Q1
$1.04M Buy
7,571
+588
+8% +$80K ﹤0.01% 3285
2017
Q4
$857K Buy
6,983
+3,766
+117% +$517K ﹤0.01% 3297
2017
Q3
$436K Sell
3,217
-788
-20% -$119K ﹤0.01% 3490
2017
Q2
$701K Buy
4,005
+3,462
+638% +$492K ﹤0.01% 3252
2017
Q1
$64K Sell
543
-611
-53% -$63.6K ﹤0.01% 4128
2016
Q4
$111K Buy
1,154
+837
+264% +$76.7K ﹤0.01% 4030
2016
Q3
$29K Sell
317
-51
-14% -$5.11K ﹤0.01% 4419
2016
Q2
$38K Buy
368
+77
+26% +$9.02K ﹤0.01% 4532
2016
Q1
$34K Sell
291
-180
-38% -$18.9K ﹤0.01% 4453
2015
Q4
$55K Sell
471
-816
-63% -$105K ﹤0.01% 4355
2015
Q3
$217K Sell
1,287
-552
-30% -$106K ﹤0.01% 3764
2015
Q2
$355K Buy
1,839
+1,500
+442% +$278K ﹤0.01% 3594
2015
Q1
$49K Sell
339
-137
-29% -$20.9K ﹤0.01% 4401
2014
Q4
$74K Buy
476
+459
+2,700% +$66.1K ﹤0.01% 4915
2014
Q3
$2K Sell
17
-437
-96% -$63.4K ﹤0.01% 5689
2014
Q2
$59K Sell
454
-916
-67% -$116K ﹤0.01% 4852
2014
Q1
$167K Buy
1,370
+487
+55% +$52.8K ﹤0.01% 3985
2013
Q4
$93K Sell
883
-2,624
-75% -$255K ﹤0.01% 4088
2013
Q3
$392K Buy
3,507
+1,320
+60% +$150K ﹤0.01% 3687
2013
Q2
$245K Buy
+2,187
New +$267K ﹤0.01% 3698

Other funds holding SRGA

Deutsche Bank's SRGA Position: Q2 2021 in Review

Deutsche Bank sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2021, closing a stake of 2,085 shares — an estimated $136K sold.

Deutsche Bank first reported a position in SRGA in Q2 2013 and held it in 32 quarters. The position peaked at $1.34M in Q3 2018. 89 funds tracked by Wall St. Rank hold SRGA as of Q2 2021.

  • Deutsche Bank reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Deutsche Bank sold 2,085 Surgalign Holdings, Inc. Common Stock shares in Q2 2021, an estimated $136K.
  • Deutsche Bank first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 32 quarters.
  • Deutsche Bank's Surgalign Holdings, Inc. Common Stock position peaked at $1.34M in Q3 2018.
  • 89 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2021.

Based on Deutsche Bank's 13F filing for Q2 2021, filed 11 Aug 2021.